Objective: To highlight management principles following brown snake envenomation.
in Australia with cardiac arrest a sign of significant envenomation. The majority of snake bites are so called 'dry bites' with no subsequent clinical consequences, though actual envenomation can have dramatic results. Venom induced consumptive coagulopathy and a positive venom detection kit result are indicators for a single vial of anti-venom. The use of FFP has been shown to normalise coagulation, though early use may worsen initial coagulopathy.
In this case the progression to cardiac arrest and subsequent global ischaemic injury is a result of absence of initial basic life support prior to presentation rather than a direct effect of envenomation.
Conclusion: Pre-hospital and initial hospital management combining pressure limb immobilisation and basic life support play a significant role in patients presenting with envenomation. The use of FFP and anti-venom are important subsequent treatments. Discipline of Child and Adolescent Health, University of Sydney, Sydney, NSW, Australia Background/Introduction: Fever in young infants is one of the most common and challenging problems faced by clinicians involved in caring for children. We aimed to implement a new, evidence-based guideline for the investigation and management of infants aged <3 months with fever at the Children's Hospital at Westmead (CHW).
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Methods: We performed a literature review and multiple rounds of discussion amongst the project team and developed a guideline for the management of febrile infants aged <3 months. The guideline was implemented in the emergency department (ED) at CHW with two formal rounds of stakeholder consultation.
We conducted an audit of consecutive infants aged <3 months presenting to CHW ED with 'fever' documented amongst their presenting complaints over corresponding 3-month periods before and after the guideline implementation. We collected data. Data including: demographics, clinical features and vital signs at presentation, investigations, management and outcomes. We compared average length of stay (LOS), proportion of children who underwent lumbar puncture, the proportion of children who received parenteral antibiotics, the proportion of children with proven serious bacterial infection (SBI) and the performance of biomarkers (white cell count (WCC), C-reactive protein (CRP), procalcitonin (PCT)) before and after guideline implementation.
Results/Outcomes: The guideline implemented over 4 months between May and August, 2015. We identified 101 infants presenting with fever prior to the implementation of the guideline and 102 post-implementation. Median age in was 46 and 40 days in the pre-implementation and postimplementation cohorts, respectively. 51% were male preimplementation group and 65% post. 34 infants were confirmed to have SBI (10 and 19, pre and post, respectively), 6 of them had IBI, 1 of them was found in pre-implementation group, and the rest from post-implementation. One patient died in the postimplementation group, with isolated UTI. A review of these cases showed that all of these cases would have been identified by the guideline. In sub-group analysis, amongst infants 29-90 days of age, non-SBI cases with blood culture performed, median LOS in hospital in pre-implementation group (n = 47) was 48 h; mean 63 h; total bed hours 3064 (128 bed days). Post-implementation (n = 48): median LOS 43 h; mean 51 h; total bed hours 2473 (103 bed days). LP was performed in 54% of these infants preimplementation and 38% post-implementation. Combined use of WCC, CRP and PCT showed a negative predictive value (NPV) of 99% for IBI and 91% for SBI. The positive predictive value (PPV) was 2 and 37% for IBI and SBI, respectively.
Conclusions: We safely and successfully implemented a guideline to risk stratify infants aged <3 months with fever
